These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9384469)

  • 41. Metabolism of irinotecan (CPT-11) by human hepatic microsomes: participation of cytochrome P-450 3A and drug interactions.
    Haaz MC; Rivory L; Riché C; Vernillet L; Robert J
    Cancer Res; 1998 Feb; 58(3):468-72. PubMed ID: 9458091
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ontogeny of hepatic microsomal 3-hydroxylation of quinine in Adélie Penguins.
    Numata M; Fawcett JP; Rosengren RJ; Wanwimolruk S
    Comp Biochem Physiol C Toxicol Pharmacol; 2004 May; 138(1):53-8. PubMed ID: 15313446
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cyclosporin A drug interactions. Screening for inducers and inhibitors of cytochrome P-450 (cyclosporin A oxidase) in primary cultures of human hepatocytes and in liver microsomes.
    Pichard L; Fabre I; Fabre G; Domergue J; Saint Aubert B; Mourad G; Maurel P
    Drug Metab Dispos; 1990; 18(5):595-606. PubMed ID: 1981707
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro inhibitory effects of plumbagin, the promising antimalarial candidate, on human cytochrome P450 enzymes.
    Sumsakul W; Chaijaroenkul W; Na-Bangchang K
    Asian Pac J Trop Med; 2015 Nov; 8(11):914-918. PubMed ID: 26614990
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Studies on the cytochrome P450 (CYP)-mediated metabolic properties of miocamycin: evaluation of the possibility of a metabolic intermediate complex formation with CYP, and identification of the human CYP isoforms.
    Kasahara M; Suzuki H; Komiya I
    Drug Metab Dispos; 2000 Apr; 28(4):409-17. PubMed ID: 10725309
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Studies on the interactions between drug and estrogen. II. On the inhibitory effect of 29 drugs reported to induce gynecomastia on the oxidation of estradiol at C-2 or C-17.
    Satoh T; Munakata H; Fujita K; Itoh S; Itoh S; Kamataki T; Yoshizawa I
    Biol Pharm Bull; 2003 May; 26(5):695-700. PubMed ID: 12736515
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Drug interactions with calcium channel blockers: possible involvement of metabolite-intermediate complexation with CYP3A.
    Ma B; Prueksaritanont T; Lin JH
    Drug Metab Dispos; 2000 Feb; 28(2):125-30. PubMed ID: 10640508
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Metabolism of taxol by human and rat liver in vitro: a screen for drug interactions and interspecies differences.
    Jamis-Dow CA; Klecker RW; Katki AG; Collins JM
    Cancer Chemother Pharmacol; 1995; 36(2):107-14. PubMed ID: 7767945
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibition of tolbutamide metabolism by antimalarial drugs.
    Karbwang J; Back DJ; Bunnag D; Breckenridge AM
    Southeast Asian J Trop Med Public Health; 1988 Jun; 19(2):235-41. PubMed ID: 3227403
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Metabolites and metabolic pathways of mesaconitine in rat liver microsomal investigated by using UPLC-MS/MS method in vitro].
    Bi YF; Liu S; Zhang RX; Song FR; Liu ZQ
    Yao Xue Xue Bao; 2013 Dec; 48(12):1823-8. PubMed ID: 24689241
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ketoconazole increases plasma concentrations of antimalarial mefloquine in healthy human volunteers.
    Ridtitid W; Wongnawa M; Mahatthanatrakul W; Raungsri N; Sunbhanich M
    J Clin Pharm Ther; 2005 Jun; 30(3):285-90. PubMed ID: 15896247
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of cytochromes P450 2C9 and 3A4 as the major catalysts of phenprocoumon hydroxylation in vitro.
    Ufer M; Svensson JO; Krausz KW; Gelboin HV; Rane A; Tybring G
    Eur J Clin Pharmacol; 2004 May; 60(3):173-82. PubMed ID: 15054565
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pathway-specific inhibition of primaquine metabolism by chloroquine/quinine.
    Fasinu PS; Tekwani BL; Avula B; Chaurasiya ND; Nanayakkara NP; Wang YH; Khan IA; Walker LA
    Malar J; 2016 Sep; 15(1):466. PubMed ID: 27618912
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antimalarial activity and interactions between quinine, dihydroquinine and 3-hydroxyquinine against Plasmodium falciparum in vitro.
    Nontprasert A; Pukrittayakamee S; Kyle DE; Vanijanonta S; White NJ
    Trans R Soc Trop Med Hyg; 1996; 90(5):553-5. PubMed ID: 8944272
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of CYP3A4 in human hepatic diltiazem N-demethylation: inhibition of CYP3A4 activity by oxidized diltiazem metabolites.
    Sutton D; Butler AM; Nadin L; Murray M
    J Pharmacol Exp Ther; 1997 Jul; 282(1):294-300. PubMed ID: 9223567
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Enzyme kinetics and inhibition of nimodipine metabolism in human liver microsomes.
    Liu XQ; Ren YL; Qian ZY; Wang GJ
    Acta Pharmacol Sin; 2000 Aug; 21(8):690-4. PubMed ID: 11501176
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cytochrome P450 isoform inhibitors as a tool for the investigation of metabolic reactions catalyzed by human liver microsomes.
    Bourrié M; Meunier V; Berger Y; Fabre G
    J Pharmacol Exp Ther; 1996 Apr; 277(1):321-32. PubMed ID: 8613937
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Activity of azithromycin or erythromycin in combination with antimalarial drugs against multidrug-resistant Plasmodium falciparum in vitro.
    Nakornchai S; Konthiang P
    Acta Trop; 2006 Dec; 100(3):185-91. PubMed ID: 17126280
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Human cytochrome P-450 3A4: in vitro drug-drug interaction patterns are substrate-dependent.
    Wang RW; Newton DJ; Liu N; Atkins WM; Lu AY
    Drug Metab Dispos; 2000 Mar; 28(3):360-6. PubMed ID: 10681383
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibition of rat liver estrogen 2/4-hydroxylase activity by troleandomycin: comparison with erythromycin and roxithromycin.
    Fisher D; Labbe G; Berson A; Tinel M; Loeper J; Larrey D; Pessayre D
    J Pharmacol Exp Ther; 1990 Sep; 254(3):1120-7. PubMed ID: 2395109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.